ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
2,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2,4,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2,5,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2,6,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
2,7,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,Y
2,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
4,1,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
4,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5,1,Renal haemorrhage,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
6,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
6,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
7,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
7,3,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
7,4,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
8,1,Appendicitis perforated,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
9,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
9,2,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
9,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
9,4,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
10,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
10,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
10,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
10,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
10,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
10,6,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
10,8,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
10,9,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
11,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
11,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
11,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11,4,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
11,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
11,6,International normalised ratio abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
11,7,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
11,8,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
11,9,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
11,10,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
11,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
12,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
12,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12,4,Renal haemorrhage,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
12,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
13,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
13,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
13,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
13,4,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
13,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
14,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
14,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
14,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
14,4,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
14,5,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
14,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
14,7,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
14,8,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
15,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
15,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
15,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
15,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
15,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
15,6,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
15,7,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
15,8,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
15,9,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
15,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
15,11,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
15,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
16,1,Appendicitis perforated,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
17,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
17,2,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
17,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
18,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
18,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
18,3,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
19,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
20,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
21,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
21,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
21,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
22,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
23,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
23,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
24,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
24,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
24,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
25,1,Polymyalgia rheumatica,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
26,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
26,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
26,3,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
27,1,Prostatomegaly,"Prostatic signs, symptoms and disorders NEC",Prostatic disorders (excl infections and inflammations),Repro,N
27,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
28,1,Meniere's disease,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
29,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
29,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
30,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
30,2,Gastrointestinal necrosis,Gastrointestinal necrosis and gangrene (excl gangrenous hernia),Gastrointestinal vascular conditions,Gastr,N
30,3,Intestinal infarction,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
31,1,Metastases to pancreas,Metastases to specified sites,Metastases,Neopl,Y
32,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
32,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
32,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
32,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
33,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
33,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
34,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
34,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
35,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
35,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
35,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
36,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
37,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
37,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
37,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
38,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
39,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
39,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
39,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
39,4,Daydreaming,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
39,5,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
39,6,Neurological decompensation,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
39,7,Slow speech,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
40,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
41,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
42,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
42,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
43,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
43,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
43,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
43,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
43,5,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
44,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
44,2,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
44,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
44,4,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
44,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
44,6,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
44,7,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
44,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
44,9,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
44,10,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
44,11,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
44,12,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
44,13,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
44,14,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
45,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
45,2,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
45,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
46,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
46,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
47,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
47,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
48,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
48,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
48,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
48,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
49,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
49,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
50,1,Hypertensive encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
51,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
52,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
53,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
53,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
53,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
53,4,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
53,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
53,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
53,7,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
53,8,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
54,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
54,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
54,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
54,4,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
54,5,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
54,6,Pneumothorax spontaneous,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
54,7,Polycythaemia,Polycythaemia (excl rubra vera),Red blood cell disorders,Blood,N
55,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
55,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
55,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
55,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
55,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
56,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
56,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
56,3,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
56,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
57,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
57,2,Headache,Headaches NEC,Headaches,Nerv,N
57,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
57,4,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
57,5,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
57,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
58,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
58,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
58,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
58,4,Headache,Headaches NEC,Headaches,Nerv,N
58,5,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
58,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
58,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
59,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
59,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
59,3,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
60,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
60,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
61,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
61,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
61,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
62,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
63,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
63,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
63,3,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,Y
63,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
64,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
65,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
66,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
66,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
66,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
67,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
67,2,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
68,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
68,2,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
68,3,Anal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
68,4,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
68,5,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
68,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
68,7,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
68,8,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
68,9,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
68,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
68,11,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
68,12,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
68,13,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
68,14,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
68,15,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
68,16,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
68,17,Perineal infection,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
68,18,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
68,19,Scrotal swelling,Scrotal disorders NEC,Penile and scrotal disorders (excl infections and inflammations),Repro,N
68,20,Thyroxine decreased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
68,21,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
69,1,Renal haemorrhage,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
70,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
70,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
70,3,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
70,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
70,5,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
70,6,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
71,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
71,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
71,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
71,4,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
71,5,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
71,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
72,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
72,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
72,3,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
72,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
72,5,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
72,6,Tumour haemorrhage,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
73,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
73,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
74,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
75,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
75,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
75,3,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
76,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
76,2,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
76,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
76,4,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
77,1,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
77,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
77,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
77,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
77,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
77,6,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
78,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
78,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
78,3,Systolic hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
79,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
79,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
79,3,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
79,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
79,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
79,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
79,7,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
79,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
79,9,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
79,10,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
79,11,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
79,12,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
79,13,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
79,14,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
80,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
80,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
80,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
80,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
80,5,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
80,6,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
80,7,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
80,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
81,1,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
81,2,Polycythaemia,Polycythaemia (excl rubra vera),Red blood cell disorders,Blood,N
82,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
82,2,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
82,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
82,4,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
82,5,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
82,6,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
83,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
84,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
85,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
86,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
86,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
86,3,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
86,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
86,5,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
86,6,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
86,7,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
86,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
86,9,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
86,10,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
86,11,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
87,1,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
88,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,Y
89,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
89,2,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
90,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
91,1,Cerebral haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
91,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
92,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
93,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
93,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
93,3,Cardiac failure,Heart failures NEC,Heart failures,Card,N
93,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
93,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
93,6,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
93,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
93,8,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
93,9,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
93,10,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
93,11,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
93,12,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
93,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
93,14,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
94,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
94,2,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
95,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
95,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
95,3,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
96,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
96,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
96,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
96,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
97,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
97,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
97,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
97,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
98,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
98,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
99,1,Groin abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
99,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
99,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
99,4,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
99,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
100,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
100,2,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
100,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
101,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
101,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
101,3,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
102,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
102,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
102,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
102,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
102,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
102,6,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
103,1,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
103,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
103,3,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
104,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
104,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
104,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
104,4,Sarcopenia,Muscle weakness conditions,Muscle disorders,Musc,N
105,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
105,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
105,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
105,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
106,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
107,1,Pneumomediastinum,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
107,2,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
107,3,Pneumothorax spontaneous,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
108,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
108,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
108,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
108,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
108,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
109,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
110,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
110,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
111,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
111,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
111,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
112,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
112,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
112,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
113,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
113,2,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
113,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
113,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
113,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
114,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
114,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
114,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
115,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
116,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
117,1,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
117,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
118,1,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
118,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
119,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
120,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
120,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
120,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
120,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
121,1,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
122,1,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
123,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
123,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
124,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
124,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
125,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
125,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
126,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
126,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
127,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
127,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
128,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
128,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
128,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
129,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
130,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
131,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
132,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
133,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
133,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
134,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
134,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
134,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
134,4,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
135,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
136,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
137,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
138,1,Blood thyroid stimulating hormone decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
138,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
138,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
138,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
138,5,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
138,6,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
138,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
139,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
139,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
140,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
141,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
141,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
141,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
141,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
141,5,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
141,6,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
142,1,Nephritis,Nephritis NEC,Nephropathies,Renal,N
143,1,Nephritis,Nephritis NEC,Nephropathies,Renal,N
144,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
144,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
145,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
146,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
147,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
147,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
148,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
148,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
149,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
149,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
150,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
150,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
151,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
152,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
153,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
154,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
154,2,Eastern Cooperative Oncology Group performance status worsened,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
154,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
155,1,Polycythaemia,Polycythaemia (excl rubra vera),Red blood cell disorders,Blood,N
156,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
157,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
158,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
159,1,Polycythaemia,Polycythaemia (excl rubra vera),Red blood cell disorders,Blood,N
160,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
161,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
161,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
161,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
162,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
163,1,Polycythaemia,Polycythaemia (excl rubra vera),Red blood cell disorders,Blood,N
164,1,Polycythaemia,Polycythaemia (excl rubra vera),Red blood cell disorders,Blood,N
165,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
166,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
167,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
168,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
168,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
168,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
168,4,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
168,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
168,6,Headache,Headaches NEC,Headaches,Nerv,N
168,7,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
168,8,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
168,9,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
169,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
170,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
170,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
170,3,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
170,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
170,5,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
170,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
170,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
170,8,Thyroxine abnormal,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
171,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
171,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
172,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
172,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
172,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
172,4,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
172,5,Headache,Headaches NEC,Headaches,Nerv,N
172,6,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
172,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
172,8,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
173,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
174,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
175,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
176,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
177,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
178,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
179,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
179,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
180,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
180,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
181,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
182,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
183,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
184,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
185,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
186,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
186,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
186,3,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
186,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
186,5,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
186,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
186,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
187,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
187,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
188,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
188,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
189,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
190,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
191,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
192,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
193,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
194,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
195,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
196,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
197,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
197,2,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
197,3,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
197,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
197,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
198,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
198,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
199,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
199,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
199,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
200,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
200,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
200,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
201,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
201,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
201,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
201,4,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
201,5,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
201,6,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
201,7,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
201,8,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
201,9,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
201,10,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
202,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
202,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
202,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
202,4,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
202,5,Pulmonary hilum mass,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
202,6,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
203,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
204,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
205,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
205,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
205,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
205,4,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
205,5,Pulmonary hilum mass,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
205,6,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
206,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
206,2,Atrial enlargement,Myocardial disorders NEC,Myocardial disorders,Card,N
206,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
206,4,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
206,5,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
206,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
206,7,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
206,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
206,9,Electrocardiogram Q wave abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
206,10,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
206,11,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
206,12,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
206,13,Systolic dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
206,14,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
207,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
207,2,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
207,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
207,4,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
207,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
208,1,Atrial enlargement,Myocardial disorders NEC,Myocardial disorders,Card,N
208,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
208,3,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
208,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
208,5,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
208,6,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
208,7,Systolic dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
208,8,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
209,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
209,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
209,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
209,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
209,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
209,6,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
209,7,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
209,8,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
209,9,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
209,10,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
209,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
210,1,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
210,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
210,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
211,1,Blood potassium abnormal,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
211,2,Blood sodium abnormal,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
211,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
212,1,Blood potassium abnormal,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
212,2,Blood sodium abnormal,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
212,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
213,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
213,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
213,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
213,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
213,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
214,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
214,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
215,1,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
215,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
215,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
216,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
216,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
216,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
216,4,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
216,5,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
217,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
217,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
217,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
218,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
219,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
219,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
220,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
220,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
221,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
221,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
221,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
222,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
222,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
223,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
223,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
224,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
225,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
225,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
226,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
227,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
227,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
227,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
228,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
228,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
228,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
229,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
230,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
231,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
231,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
231,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
232,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
232,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
232,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
233,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
233,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
234,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
234,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
235,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
235,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
235,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
235,4,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
235,5,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
235,6,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
235,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
236,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
236,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
237,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
238,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
238,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
239,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
239,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
240,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
240,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
240,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
241,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
242,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
242,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
243,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
243,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
244,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
244,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
245,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
246,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
247,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
248,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
249,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
249,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
250,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
251,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
252,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
252,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
252,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
253,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
253,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
253,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
254,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
254,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
254,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
255,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
255,2,Eastern Cooperative Oncology Group performance status worsened,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
256,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
256,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
257,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
257,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
258,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
258,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
259,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
259,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
260,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
260,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
260,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
261,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
261,2,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
262,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
262,2,Eastern Cooperative Oncology Group performance status worsened,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
263,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
264,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
265,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
266,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
267,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
267,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
268,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
269,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
270,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
271,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
272,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
272,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
273,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
273,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
274,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
274,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
275,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
275,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
275,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
276,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
276,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
277,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
277,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
278,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
278,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
278,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
279,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
279,2,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
279,3,Papillary renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
280,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
280,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
280,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
281,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
281,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
281,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
282,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
282,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
282,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
283,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
283,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
284,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
284,2,Drug titration error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
284,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
285,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
285,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
286,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
287,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
288,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
289,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
289,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
290,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
290,2,Migraine,Migraine headaches,Headaches,Nerv,N
291,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
291,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
291,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
292,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
292,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
292,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
293,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
293,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
293,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
294,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
294,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
295,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
295,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
295,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
296,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
296,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
297,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
297,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
298,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
299,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
300,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
301,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
302,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
303,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
304,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
305,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
306,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
307,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
308,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
308,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
309,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
310,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
311,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
311,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
311,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
311,4,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
312,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
312,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
312,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
313,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
313,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
314,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
315,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
316,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
316,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
317,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
318,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
319,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
319,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
320,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
320,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
321,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
321,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
321,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
322,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
322,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
323,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
324,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
325,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
326,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
326,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
327,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
328,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
329,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
329,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
329,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
329,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
330,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
331,1,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
331,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
331,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
331,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
332,1,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
332,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
332,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
332,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
333,1,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
334,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
334,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
335,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
336,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
337,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
337,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
337,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
338,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
338,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
338,3,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
338,4,Metastases to stomach,Metastases to specified sites,Metastases,Neopl,N
338,5,Metastases to uterus,Metastases to specified sites,Metastases,Neopl,N
339,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
339,2,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
340,1,Gingival disorder,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
340,2,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
341,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
341,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
342,1,Immune-mediated nephritis,Nephritis NEC,Nephropathies,Renal,N
342,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
343,1,Immune-mediated nephritis,Nephritis NEC,Nephropathies,Renal,N
343,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
344,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
344,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
344,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
344,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
345,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
345,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
345,3,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
345,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
345,5,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
345,6,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
345,7,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
345,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
345,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
345,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
346,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
346,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
346,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
346,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
347,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
347,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
347,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
347,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
347,5,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
348,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
348,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
348,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
348,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
348,5,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
349,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
349,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
349,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
349,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
350,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
350,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
350,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
350,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
351,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
351,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
351,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
351,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
352,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
352,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
352,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
352,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
353,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
354,1,Atelectasis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
354,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
354,3,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
355,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
355,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
355,3,Transaminases abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
356,1,Transaminases abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
357,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
357,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
358,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
359,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
360,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
